Zurich Cantonal Bank’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Zurich Cantonal Bank’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-62,143	Closed	-$2.69M	–	2599
2015 Q3	$2.69M	Buy	62,143 +20,106	+48%	+$848K	0.04%	429
2015 Q2	$1.78M	Sell	42,037 -8,963	-18%	-$378K	0.02%	565
2015 Q1	$1.98M	Buy	+51,000	New	+$1.96M	0.03%	531
2014 Q2	–	Sell	-102,320	Closed	-$3.77M	–	1017
2014 Q1	$3.77M	Sell	102,320 -5,340	-5%	-$196K	0.12%	195
2013 Q4	$4.13M	Buy	+107,660	New	+$3.4M	0.14%	170

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Zurich Cantonal Bank's WX Position: Q4 2015 in Review

Zurich Cantonal Bank sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 62,143 shares — an estimated $2.69M sold.

Zurich Cantonal Bank first reported a position in WX in Q4 2013 and held it in 5 quarters. The position peaked at $4.13M in Q4 2013. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Zurich Cantonal Bank reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Zurich Cantonal Bank sold 62,143 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $2.69M.
Zurich Cantonal Bank first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 5 quarters.
Zurich Cantonal Bank's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $4.13M in Q4 2013.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Zurich Cantonal Bank's 13F filing for Q4 2015, filed 29 Jan 2016.